干细胞超级大佬学术造假；华润子企业假药劣药问题显著|共两条快讯
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;"><img src="https://mmbiz.qpic.cn/mmbiz_gif/jrb7YPOxsiapp0enzmyXrROdBBNMaQjib8sLXztrTmUibicotMUr9z51SnxbQYCXjk1vh6CricI5cLo1LGwOch6icLibA/640?wx_fmt=gif&wxfrom=5&wx_lazy=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></strong></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;">共计2条简讯 | 阅读时间约为2</span><span style="color: black;">分钟 <span style="color: black;"><strong style="color: blue;">◆</strong></span><strong style="color: blue;"> ◆ ◆</strong></span></strong></span></p><strong style="color: blue;"><img src="https://mmbiz.qpic.cn/mmbiz_png/jrb7YPOxsiap2bSAym3ZOB0pp6hnAOCGdBB9vPQumkvxYlLulXiaab8HneviaBmGom9sIJaIict8Ubiaic3uJGaoics9Q/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></strong><strong style="color: blue;"><span style="color: black;">01</span></strong><strong style="color: blue;"><span style="color: black;"><img src="https://mmbiz.qpic.cn/mmbiz_png/jrb7YPOxsiap2bSAym3ZOB0pp6hnAOCGdlXGCOv70cdGF50vkR0XiaxFBztTu8zE5DAicKmXEKmesbOTLdb7iberaw/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></span></strong>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;"><span style="color: black;"><span style="color: black;"><span style="color: black;">干细胞超级大佬学术造假</span></span></span></span></strong></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">2024年6月份，干细胞学术界<span style="color: black;">出现</span>了一件震惊中外的撤稿事件。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">2024年6月17日，《nature》杂志宣布正式撤回干细胞<span style="color: black;">科研</span><span style="color: black;">行业</span>的一位超级大佬Catherine Verfaillie教授在2002年<span style="color: black;">发布</span>在《nature》杂志的一篇<span style="color: black;">文案</span>“Pluripotency of mesenchymal stem cells derived from adult marrow”。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">这篇<span style="color: black;">文案</span><span style="color: black;">拥有</span>非常重大的<span style="color: black;">道理</span>，证明间充质干细胞（Mesenchymal Stem Cells，MSC）在体外和<span style="color: black;">身体</span><span style="color: black;">能够</span>分化多种<span style="color: black;">区别</span>组织器官的特定细胞，推动了MSC的体外分化<span style="color: black;">科研</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">谷歌的学术检索<span style="color: black;">表示</span>这篇<span style="color: black;">文案</span>的引用次数高达8699次（截止于检索当时）。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">这是非常恐怖的一个引用次数，这篇<span style="color: black;">文案</span>的影响力可见一斑。这<span style="color: black;">亦</span>是每一位<span style="color: black;">研究</span>工作者梦寐以求的非常自豪的引用次数。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">著名学术打假人Elisabeth Bik等人曾在PubPeer平台上对Catherine Verfaillie教授的论文提出质疑，<span style="color: black;">可疑</span>Catherine Verfaillie教授在论文中数据处理和图像<span style="color: black;">运用</span>上有造假嫌疑，并<span style="color: black;">暗示</span>Catherine Verfaillie教授的这些<span style="color: black;">科研</span>结果的真实性和<span style="color: black;">靠谱</span>性存疑。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">这篇<span style="color: black;">文案</span>曾经在2007年<span style="color: black;">发布</span>了<span style="color: black;">关联</span>的更正声明，但作者们<span style="color: black;">保持</span>这些失误“并未改变<span style="color: black;">文案</span>的结论”。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">这篇<span style="color: black;">文案</span><span style="color: black;">最后</span>因为作者<span style="color: black;">没法</span><span style="color: black;">供给</span>原始<span style="color: black;">照片</span>数据，<span style="color: black;">没法</span>洗清数据造假的嫌疑，《nature》杂志于2024年6月17日撤回了这篇影响力巨大的<span style="color: black;">文案</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">当然，<span style="color: black;">咱们</span>不清楚这篇<span style="color: black;">文案</span>的通讯作者（即Catherine Verfaillie教授）和<span style="color: black;">第1</span>作者（即Yuehua Jiang）谁来<span style="color: black;">重点</span>负责这篇<span style="color: black;">文案</span>的数据造假。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">Catherine Verfaillie教授曾在明尼苏达大学干细胞<span style="color: black;">科研</span>所工作，<span style="color: black;">发布</span>了多篇重要的<span style="color: black;">研究</span>论文，后来转至荷兰鲁汶大学（KU Leuven），担任该校干细胞<span style="color: black;">科研</span>所所长。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">Catherine Verfaillie教授的多篇干细胞<span style="color: black;">文案</span>涉嫌“数据造假”，<span style="color: black;">那样</span><span style="color: black;">咱们</span><span style="color: black;">是不是</span><span style="color: black;">能够</span>认为Catherine Verfaillie教授靠着专业的数据造假来走上人生巅峰？</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">上一次干细胞<span style="color: black;">行业</span>的重磅造假事件的主角为哈佛大学终身教授Piero Anversa教授。</span><span style="color: black;"><span style="color: black;">不外</span>，Piero Anversa教授造假的干细胞种类为心肌干细胞和肺干细胞，并不是间充质干细胞（MSC）。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">【总结和体会】</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">干细胞<span style="color: black;">行业</span>的学术造假<span style="color: black;">是不是</span>盛行？</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">间充质干细胞（MSC）虽然有分化功能，<span style="color: black;">然则</span>这个分化功能并不强大，远弱于胚胎干细胞和诱导的多钱能干细胞（iPS），<span style="color: black;">况且</span>更重要的是间充质干细胞并不是<span style="color: black;">经过</span>分化功能来发挥治疗<span style="color: black;">功效</span>，间充质干细胞进入人体后，<span style="color: black;">亦</span><span style="color: black;">由于</span><span style="color: black;">身体</span>免疫系统的存在而<span style="color: black;">没法</span>进行分化。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">因此</span>，间充质干细胞的分化<span style="color: black;">科研</span>，<span style="color: black;">能够</span>暂告一段落了，并<span style="color: black;">无</span><span style="color: black;">实质</span><span style="color: black;">道理</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">（<span style="color: black;">源自</span>：</span><span style="color: black;">干细胞者说）</span></p><strong style="color: blue;"><img src="https://mmbiz.qpic.cn/mmbiz_png/jrb7YPOxsiap2bSAym3ZOB0pp6hnAOCGdBB9vPQumkvxYlLulXiaab8HneviaBmGom9sIJaIict8Ubiaic3uJGaoics9Q/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></strong><strong style="color: blue;"><span style="color: black;">02</span></strong><strong style="color: blue;"><span style="color: black;"><img src="https://mmbiz.qpic.cn/mmbiz_png/jrb7YPOxsiap2bSAym3ZOB0pp6hnAOCGdlXGCOv70cdGF50vkR0XiaxFBztTu8zE5DAicKmXEKmesbOTLdb7iberaw/640?wx_fmt=other&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></span></strong>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;"><span style="color: black;"><span style="color: black;"><span style="color: black;">华润子<span style="color: black;">机构</span></span><span style="color: black;">假药劣药问题<span style="color: black;">明显</span></span></span></span></span></strong></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年<span style="color: black;">败兴</span>，国家对医疗医药<span style="color: black;">行业</span>的监管力度<span style="color: black;">显著</span>加强，针对医药乱象重拳出击、严肃整顿，在很大程度上<span style="color: black;">处理</span>了老<span style="color: black;">大众</span>身边的医疗<span style="color: black;">败北</span>、医药违规现象。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">华润医药，<span style="color: black;">做为</span>医疗医药<span style="color: black;">行业</span>的国家队，其合规内控、<span style="color: black;">机构</span>治理等方面<span style="color: black;">一样</span>会受到社会公众的审视。只<span style="color: black;">不外</span><span style="color: black;">做为</span>医药“航母”来讲，规模大了，难免会在身上<span style="color: black;">发掘</span><span style="color: black;">有些</span>问题。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">不外</span>在作者看来，有些问题是<span style="color: black;">不该</span>该在医药国家队身上<span style="color: black;">显现</span>的，<span style="color: black;">况且</span>相比于其他医药企业<span style="color: black;">来讲</span>，华润医药的表现<span style="color: black;">乃至</span>不如后者，<span style="color: black;">例如</span>在华润医药下属的子<span style="color: black;">机构</span>或控股<span style="color: black;">机构</span>中，假药、劣药的问题还比较<span style="color: black;">明显</span>，部分<span style="color: black;">机构</span><span style="color: black;">显现</span>环保违规、弄虚作假的现象还比较严重，这些<span style="color: black;">机构</span>治理和内部管控方面的短板严重损害到了华润医药的品牌形象，亟需管理层<span style="color: black;">导致</span><span style="color: black;">注重</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">弄虚作假、环保违规现象严重，</span><span style="color: black;">曾因价格垄断被罚超千万</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">日前，军队采购网对一批医药企业在军队采购中的违规<span style="color: black;">行径</span>进行了通报，其中国药集团下属企业<span style="color: black;">成为了</span>重灾区，<span style="color: black;">不外</span>华润医药旗下<span style="color: black;">亦</span>有两家<span style="color: black;">机构</span>上榜。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">公示信息<span style="color: black;">表示</span>，华润河南医药有限<span style="color: black;">机构</span>在参加智能化战创伤模拟人项目（项目编码：</span><span style="color: black;">JZD-2019-063）项目采购活动中，存在招标文件未<span style="color: black;">知道</span>应答模板，但与其他<span style="color: black;">机构</span>投标文件商务条款响应中知识产权、概述、付款及结算方式等内容完全一致等违规<span style="color: black;">行径</span>，其<span style="color: black;">行径</span><span style="color: black;">已然</span>触及到了串标红线，被处以禁止3年内参加联勤<span style="color: black;">保证</span>部队范围<span style="color: black;">所有</span><span style="color: black;">制品</span>类别采购活动。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">与此<span style="color: black;">同期</span>，华润重庆医药<span style="color: black;">机构</span>则因违规被<span style="color: black;">加入</span>军队暂停采购的供应商名单。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">今年4月份，华润医药旗下华润双鹤全资子<span style="color: black;">机构</span>安徽双鹤药业有限<span style="color: black;">机构</span>，<span style="color: black;">由于</span><span style="color: black;">供给</span>不真实的统计资料，被安徽省统计局责令改正，并处以警告和1万元罚款。央企上市<span style="color: black;">机构</span>居然向统计<span style="color: black;">分部</span><span style="color: black;">供给</span>不真实的统计资料，实在是匪夷所思，<span style="color: black;">机构</span>数据的严肃和合规性在哪里？</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年8月份，华润新龙北京医药<span style="color: black;">机构</span><span style="color: black;">亦</span>被北京市统计局查出该<span style="color: black;">机构</span><span style="color: black;">供给</span>不真实的统计资料，从而被公开处罚。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">此刻</span>著名的保健品上市<span style="color: black;">机构</span>东阿阿胶的控股股东<span style="color: black;">亦</span>变<span style="color: black;">成为了</span>华润医药，董事长、总裁、副总裁等一众高管都从华润医药派过去了，<span style="color: black;">然则</span>华润医药在对该<span style="color: black;">机构</span>的合规经营方面显然存在瑕疵。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">就在今年1月份，东阿阿胶的电商营销平台东阿阿胶电子商务（北京）有限<span style="color: black;">机构</span>，在网络直播间公然宣<span style="color: black;">叫作</span>6岁以上小孩能吃阿胶，且未<span style="color: black;">知道</span>阿胶是保健品还是普通食品，并在直播中对阿胶的性能、功能、产地、质量、<span style="color: black;">成份</span>、价格等信息表述不清楚、不明白，且该直播未经审查就发布保健品<span style="color: black;">宣传</span>，<span style="color: black;">乃至</span>还有诱骗消费者交易的情形，<span style="color: black;">以上</span><span style="color: black;">行径</span>违反了<span style="color: black;">宣传</span>法、价格法等<span style="color: black;">关联</span>法律法规规定，被处以11万元的重罚。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">医药行业<span style="color: black;">做为</span>用水大户和污染高发行业，华润医药旗下<span style="color: black;">机构</span><span style="color: black;">亦</span>存在这个通病。华润医药旗下另一家上市<span style="color: black;">机构</span>江中药业的控股子<span style="color: black;">机构</span>晋城海斯制药，今年1月份<span style="color: black;">由于</span>VOC处理设备（喷淋塔）<span style="color: black;">不可</span>正常<span style="color: black;">运用</span>，从而被晋城市生态环境局重罚4.4万元。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年6月份，华润医药旗下双鹤药业商丘有限责任<span style="color: black;">机构</span>因未报批环评文件被处罚，且该<span style="color: black;">机构</span>未<span style="color: black;">根据</span>监管<span style="color: black;">需求</span>将企业的非甲烷总在线监控设备与国发平台联网，违反了排污许可管理规定，<span style="color: black;">以上</span>两项违法<span style="color: black;">行径</span>被处以近10万元罚款；</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">另外</span>，在去年还有一件<span style="color: black;">很强</span>的事情，<span style="color: black;">便是</span>华润医药旗下华润双蛾的控股子<span style="color: black;">机构</span>北京紫竹医药经营有限<span style="color: black;">机构</span>，因触犯了反垄断法，被处以1264万元的天价处罚。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">处罚信息<span style="color: black;">表示</span>，北京紫竹医药经营有限<span style="color: black;">机构</span>与交易相对人达<span style="color: black;">成为了</span>固定向第三人转售商品的价格、并限定了向第三人转售商品的最低价格，该<span style="color: black;">行径</span>触犯了反垄断法的第46条<span style="color: black;">第1</span>款，<span style="color: black;">因此呢</span>被市场监管<span style="color: black;">分部</span>予以查处。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">从<span style="color: black;">以上</span>多个案例来看，无论是招投标、统计资料、宣传营销等方面的弄虚作假，还是环保<span style="color: black;">行业</span>的违法违规，<span style="color: black;">乃至</span><span style="color: black;">经过</span>协议进行价格垄断等，都凸显了华润医药在对这艘“行业航母”内部管控上的短板，管理问题马虎不得。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">假药劣药问题<span style="color: black;">明显</span>，</span><span style="color: black;">央企责任担当在<span style="color: black;">哪里</span>？</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">倘若</span>说，华润医药在管理上的问题还能<span style="color: black;">谅解</span>的话，<span style="color: black;">那样</span>在医药<span style="color: black;">制品</span>上的问题恐怕要重点关注<span style="color: black;">乃至</span>问责了。<span style="color: black;">药物</span>的质量是医药企业的生命线和底线啊！</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年年底，福建省<span style="color: black;">药物</span>监管<span style="color: black;">分部</span>对华润（三明）医药有限<span style="color: black;">机构</span>进行了查处，该<span style="color: black;">机构</span><span style="color: black;">营销</span>的板蓝根中药饮片的性状不符合<span style="color: black;">关联</span>规定，<span style="color: black;">制品</span>品质不合格被认定为劣药，处罚的<span style="color: black;">同期</span>还<span style="color: black;">需求</span>对劣药进行召回；</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年9月和11月份，江苏省<span style="color: black;">药物</span>监管<span style="color: black;">分部</span>对华润无锡医药有限<span style="color: black;">机构</span>进行了处罚，<span style="color: black;">由于</span>监管<span style="color: black;">分部</span>在对华润无锡医药<span style="color: black;">营销</span>的一款<span style="color: black;">药物</span>的鉴定中，<span style="color: black;">发掘</span>“薄层色谱”未检出与橙皮苷对照品相应的斑点，属于“<span style="color: black;">药物</span>所含<span style="color: black;">成分</span>与国家<span style="color: black;">药物</span>标准规定的<span style="color: black;">成分</span>不符”的情形，直接被认定为假药。一家央企背景的医药<span style="color: black;">机构</span>居然<span style="color: black;">营销</span>假药，这在行业内恐怕<span style="color: black;">亦</span>是令人瞠目结舌的<span style="color: black;">状况</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">去年8月份，华润立方药业（安徽）有限<span style="color: black;">机构</span>被安徽省药监<span style="color: black;">分部</span>查处<span style="color: black;">发掘</span><span style="color: black;">营销</span>劣质药的<span style="color: black;">状况</span>；同月福建省<span style="color: black;">药物</span>监管<span style="color: black;">分部</span>对华润东大（福建）医药有限<span style="color: black;">机构</span>进行了处罚，<span style="color: black;">由于</span>该<span style="color: black;">机构</span>向泉州当地卫生服务中心<span style="color: black;">营销</span>的氯化钠注射液不合格，属于劣药范畴。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">以上</span>多起的劣药、假药案件，<span style="color: black;">亦</span>凸显了华润医药在<span style="color: black;">药物</span>质量把控方面存在的<span style="color: black;">很强</span>隐患，<span style="color: black;">已然</span>被监管<span style="color: black;">分部</span>查处的案件在短期内就有这么多，过往<span style="color: black;">出现</span>的、或<span style="color: black;">无</span>被查处的呢？这些内部品质把控的短板，确实需要华润医药进一步思考的问题。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">（<span style="color: black;">源自</span>：九号观察）</span></p><strong style="color: blue;"><span style="color: black;">—精彩回顾—</span></strong>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><a style="color: black;">阿尔兹海默病里程碑新药开出首方</a><a style="color: black;">诺和诺德两款新药在<span style="color: black;">博客</span>赚足“自来水”</a></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><a style="color: black;"><span style="color: black;">1星期</span>一次！胰岛素里程碑新药正式<span style="color: black;">获准</span></a><a style="color: black;">集采升级，定向</a>爆破大品种</p><a style="color: black;">原研药的江山，可能守不住了</a>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/jrb7YPOxsiarPPtALQPl5vzaFEAkbK5x60UVjmXhcBC6qvecUZMwic3SWvlDf5CPv0QLs5prI3E97jiaKzjRg1p1Q/640?wx_fmt=other&from=appmsg&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;"></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;"><img src="data:image/svg+xml,%3C%3Fxml version=1.0 encoding=UTF-8%3F%3E%3Csvg width=1px height=1px viewBox=0 0 1 1 version=1.1 xmlns=http://www.w3.org/2000/svg xmlns:xlink=http://www.w3.org/1999/xlink%3E%3Ctitle%3E%3C/title%3E%3Cg stroke=none stroke-width=1 fill=none fill-rule=evenodd fill-opacity=0%3E%3Cg transform=translate(-249.000000, -126.000000) fill=%23FFFFFF%3E%3Crect x=249 y=126 width=1 height=1%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E" style="width: 50%; margin-bottom: 20px;"></strong></p>
我完全赞同你的观点，思考很有深度。 感谢你的精彩评论，带给我新的思考角度。
页:
[1]